175 related articles for article (PubMed ID: 29726359)
1. Patients Undergoing Radiation Therapy Are at Risk of Financial Toxicity: A Patient-based Prospective Survey Study.
Palmer JD; Patel TT; Eldredge-Hindy H; Keith SW; Patel T; Malatesta T; DiNome J; Lowther A; Ferguson L; Wagenborg S; Smyles J; Babaria U; Stabile R; Gressen E; Rudoler S; Fisher SA
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):299-305. PubMed ID: 29726359
[TBL] [Abstract][Full Text] [Related]
2. Development of a Financial Toxicity Screening Tool for Radiation Oncology: A Secondary Analysis of a Pilot Prospective Patient-Reported Outcomes Study.
Prasad RN; Patel TT; Keith SW; Eldredge-Hindy H; Fisher SA; Palmer JD
Adv Radiat Oncol; 2021; 6(6):100782. PubMed ID: 34660939
[TBL] [Abstract][Full Text] [Related]
3. Financial toxicity in gynecologic oncology.
Bouberhan S; Shea M; Kennedy A; Erlinger A; Stack-Dunnbier H; Buss MK; Moss L; Nolan K; Awtrey C; Dalrymple JL; Garrett L; Liu FW; Hacker MR; Esselen KM
Gynecol Oncol; 2019 Jul; 154(1):8-12. PubMed ID: 31053404
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported Outcome.
D'Rummo KA; Miller L; TenNapel MJ; Shen X
Pract Radiat Oncol; 2020; 10(5):e322-e329. PubMed ID: 31634632
[TBL] [Abstract][Full Text] [Related]
5. Financial Toxicity and Cancer Therapy: A Primer for Radiation Oncologists.
Schroeder SR; Agusala V; Sher DJ
Hematol Oncol Clin North Am; 2019 Dec; 33(6):1117-1128. PubMed ID: 31668210
[TBL] [Abstract][Full Text] [Related]
6. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
[TBL] [Abstract][Full Text] [Related]
7. The influence of age on perceptions of anticipated financial inadequacy by palliative radiation outpatients.
Francoeur RB
Patient Educ Couns; 2007 Dec; 69(1-3):84-92. PubMed ID: 17766078
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Prevalence of Financial Toxicity, its Predictors and Association with Health- Related Quality of Life Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported Outcome Study.
Dar MA; Chauhan R; Trivedi V; Kumar R; Dhingra S
Int J Radiat Oncol Biol Phys; 2023 May; 116(1):157-165. PubMed ID: 36455689
[TBL] [Abstract][Full Text] [Related]
9. It Is Time to Ask About Financial Toxicity.
Fessele KL
Clin J Oncol Nurs; 2019 Oct; 23(5):3-4. PubMed ID: 31538987
[TBL] [Abstract][Full Text] [Related]
10. Financial Support Models: A Case for Use of Financial Navigators in the Oncology Setting.
Sherman D; Fessele KL
Clin J Oncol Nurs; 2019 Oct; 23(5):14-18. PubMed ID: 31538990
[TBL] [Abstract][Full Text] [Related]
11. Setting the stage for universal financial distress screening in routine cancer care.
Khera N; Holland JC; Griffin JM
Cancer; 2017 Nov; 123(21):4092-4096. PubMed ID: 28817185
[TBL] [Abstract][Full Text] [Related]
12. Patient-Reported Financial Toxicity Associated With Management of Nephrolithiasis.
Setia SA; Gelikman DG; Cabo J; Hsi RS
Urology; 2023 Apr; 174():52-57. PubMed ID: 36708930
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.
Riva S; Bryce J; De Lorenzo F; Del Campo L; Di Maio M; Efficace F; Frontini L; Giannarelli D; Gitto L; Iannelli E; Jommi C; Montesarchio V; Traclò F; Vaccaro CM; Gallo C; Perrone F
BMJ Open; 2019 Sep; 9(9):e031485. PubMed ID: 31501130
[TBL] [Abstract][Full Text] [Related]
14. The utility of cost discussions between patients with cancer and oncologists.
Zafar SY; Chino F; Ubel PA; Rushing C; Samsa G; Altomare I; Nicolla J; Schrag D; Tulsky JA; Abernethy AP; Peppercorn JM
Am J Manag Care; 2015 Sep; 21(9):607-15. PubMed ID: 26618364
[TBL] [Abstract][Full Text] [Related]
15. A growing side effect of cancer care: Financial toxicity: Researchers are taking a closer look at the financial ruin and other disastrous consequences that can accompany escalating costs of cancer care.
Nelson B
Cancer Cytopathol; 2019 Nov; 127(11):673-674. PubMed ID: 31710419
[No Abstract] [Full Text] [Related]
16. The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment.
Carrera PM; Kantarjian HM; Blinder VS
CA Cancer J Clin; 2018 Mar; 68(2):153-165. PubMed ID: 29338071
[TBL] [Abstract][Full Text] [Related]
17. Patient Attitudes Regarding the Cost of Illness in Cancer Care.
Meisenberg BR; Varner A; Ellis E; Ebner S; Moxley J; Siegrist E; Weng D
Oncologist; 2015 Oct; 20(10):1199-204. PubMed ID: 26330457
[TBL] [Abstract][Full Text] [Related]
18. Patient Assistance Programs: Easing the Burden of Financial Toxicity During Cancer Treatment.
McMullen L
Clin J Oncol Nurs; 2019 Oct; 23(5):36-40. PubMed ID: 31538988
[TBL] [Abstract][Full Text] [Related]
19. Financial and employment impacts of serious injury: a qualitative study.
Gabbe BJ; Sleney JS; Gosling CM; Wilson K; Sutherland A; Hart M; Watterson D; Christie N
Injury; 2014 Sep; 45(9):1445-51. PubMed ID: 24560090
[TBL] [Abstract][Full Text] [Related]
20. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
